Table 2.
Clinical and biochemical characteristics of the study participants in the quercetin and placebo groups
| Baseline Characteristic | Quercetin n=42 | Placebo n=40 | P value* |
|---|---|---|---|
| Age (Y) | 29.45 (4.09) | 30.00 (5.44) | 0.607 |
| Weight) kg) | 76.46 (11.89) | 74.89 (11.74) | 0.550 |
| BMI (kg/m2) | 29.32 (3.71) | 28.61 (4.06) | 0.411 |
| WHR(cm) | 0.83 (0.02) | 0.83 (0.02) | 0.233 |
| SBP(mmHg) | 12.63 (0.66) | 12.56 (0.67) | 0.644 |
| DBP(mmHg) | 8.79 (0.72) | 8.43 (0.64) | 0.018 |
| FBS (mg/dL) | 91.57 (6.74) | 89.83 (6.36) | 0.231 |
| Insulin (μIU/mL) | 10.09 (2.78) | 9.91 (2.56) | 0.754 |
| HOMA-IR | 2.28 (0.72) | 2.20 (0.68) | 0.604 |
| SHBG ( nmol/l) | 41.04 (17.73) | 35.62 (13.04) | 0.120 |
| LH(mIU/ml) | 8.40 (3.03) | 8.67 (2.07) | 0.644 |
| Testosterone | 0.78 (0.16) | 0.78 (0.15) | 0.941 |
| Adiponectin (Total) (ng/mL) | 9.58 (1.80) | 10.05 (1.24) | 0.163 |
| Adiponectin (HMW) | 5.12 (1.01) | 5.30 (0.91) | 0.421 |
| All values are mean (SD). BMI; Body mass index, WHR; Waist to hip ratio, SBP; Systolic blood pressure, DBP; Diastolic blood pressure, FBS; Fasting blood sugar, LH; Luteinizing hormone, SHBG; Sex hormone binding globulin LH, HOMA-IR; Homeostasis model assessment-insulin resistance, HMW; High molecular weight, and *; Significances are based on independent t test. | |||
All values are mean (SD). BMI; Body mass index, WHR; Waist to hip ratio, SBP; Systolic blood pressure, DBP; Diastolic blood pressure, FBS; Fasting blood sugar, LH; Luteinizing hormone, SHBG; Sex hormone binding globulin LH, HOMA-IR; Homeostasis model assessment-insulin resistance, HMW; High molecular weight, and *; Significances are based on independent t test.